Acadia Healthcare (NASDAQ:ACHC) Stock Price Breaks Above 200 Day Moving Average - What's Next?

Key Points

• Acadia Healthcare shares broke above their 200-day moving average, reaching $28.92 and last trading at $28.87, compared with the 200-day average of $27.53.
• Analyst sentiment is mixed: eight analysts rate ACHC a Buy, five Hold, and two Sell. The consensus rating is Hold, with an average price target of $30.69, while several firms set targets near $39–$40.
• The company exceeded quarterly expectations with $0.38 in EPS versus $0.35 forecast and revenue of $865.84 million, although revenue declined 0.4% year over year and net margin remained negative. Major institutions including BlackRock and Jefferies recently initiated sizable positions.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $27.53 and traded as high as $28.92. Acadia Healthcare shares last traded at $28.87, with a volume of 2,431,127 shares trading hands.

Analysts Set New Price Targets

ACHC has been the subject of several research analyst reports. KeyCorp boosted their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 14th. Guggenheim lifted their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a report on Thursday, July 30th. UBS Group upped their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research report on Thursday, July 9th. Raymond James Financial downgraded shares of Acadia Healthcare from a "strong-buy" rating to an "outperform" rating and set a $39.00 price objective for the company. in a research note on Monday, September 28th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Acadia Healthcare currently has an average rating of "Hold" and an average target price of $30.69.

Acadia Healthcare Price Performance

The company has a 50 day moving average price of $28.97 and a 200-day moving average price of $27.53. The company has a market cap of $2.69 billion, a price-to-earnings ratio of -2.32, a P/E/G ratio of 9.04 and a beta of 0.63. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company's revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the firm earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Acadia Healthcare in the 2nd quarter worth about $441,685,000. Jefferies Financial Group Inc. bought a new stake in shares of Acadia Healthcare during the 2nd quarter valued at about $106,458,000. Deutsche Bank AG acquired a new stake in Acadia Healthcare during the second quarter worth approximately $49,746,000. Invenomic Capital Management LP increased its holdings in Acadia Healthcare by 71.0% in the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company's stock worth $46,998,000 after purchasing an additional 1,375,647 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. acquired a new position in Acadia Healthcare in the first quarter valued at approximately $43,017,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.

Acadia's services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.